Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer

NCT02092298 ↗

Phase 2 Completed 21 enrolled M.D. Anderson Cancer Center

NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to learn if hyperthermic intraperitoneal chemotherapy (HIPEC) will help to control the disease in patients with Stage 4 stomach or gastroesophageal cancer. The safety of this treatment will also be studied.

Timeline

Start: 2014-05-08
Primary completion: 2020-05-12
Completion: 2020-05-12

Publications

Badgwell B, Blum M, Das P, Estrella J, Wang X, Fournier K, Royal R, Mansfield P, Ajani J. Lessons learned from a phase II clinical trial of laparoscopic HIPEC for gastric cancer. Surg Endosc. 2018 Jan;32(1):512. doi: 10.1007/s00464-017-5668-9. Epub 2017 Jun 22.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cisplatin	Other / unclassified	200 mg	Other
Subject	Mitomycin C	Other / unclassified	30 mg	Other
Background	Sodium Thiosulfate	Diagnostic / imaging agent	25560 mg/m2	Intravenous

Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer

Summary

Timeline

Publications

Drugs

Indications